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Background:  Several studies showed peri-contrast staining (PSS) after silorimus-eluting stent was be associated with target-lesion 
revascularization (TLR) and very late stent thrombosis. However, the incidence and clinical sequela of PSS after second generation DES 
implantation are unclear, so we retrospectively evaluate the clinical outcomes.
methods:  This study consisted of de novo 2456 lesions in 1955 patients that were treated with second generation DES (zotarolimus-
eluting stent: ZES, everolimus-eluting stent: EES, and biolimus-eluting stent: BES). They were evaluated by follow-up angiography within 
12 months after stent implantation, from April 2009 to March 2013. We divided into PSS group and non-PSS group and compared the two 
groups in clinical and angiographical outcomes.
results:  We had obtained 2069 lesions follow-up angiography. (84.2%) The mean clinical follow up period was 668±316 days. Baseline 
clinical and angiographic characteristics were similar between the two groups. (N.S.) Late acquired PSS was observed in 18 lesions 
(0.73%). In these lesions, 2 lesions (0.08%) were observed in BES, 9 lesions (0.37%) were EES and 7 lesions (0.29%) were ZES. (N.S.) 
Stent fracture (SF), tortuosity, and hinge motion were more frequently observed in lesions with PSS than in lesions without PSS (11.1% 
versus 1.6%, p=0.03, 11.1% versus 1.2%, p=0.02, 11.1% versus 1.8%, p=0.04). Cumulative incidence of TLR and MACE in the PSS group 
was higher than that in the non-PSS group. (38.9% versus 5.7 %, and 44.4% versus 9.2%, p<0.0001). There was no significant difference 
in late and very late stent thrombosis between the two groups. (N.S.) After multivariable analysis, CTO (OR: 4.18, 95% CI: 1.1 to 13.3, 
p=0.04), and reference diameter (>2.83mm) (OR: 4.05, 95% CI: 1.5 to 12.3, p = 0.007) were independent predictors for PSS.
Conclusion:  PSS after second generation DES was a rare phenomenon but appeared to be associated with subsequent TLR.
